Onward Medical N.V. (ONWRF)

Market Cap	229.69M +13.2%
Revenue (ttm)	6.36M +211.3%
Net Income	-49.06M
EPS	-1.06
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	300
Open	3.300
Previous Close	2.975
Day's Range	3.300 - 3.300
52-Week Range	2.975 - 6.370
Beta	0.86
Analysts	n/a
Price Target	n/a
Earnings Date	May 26, 2026

About Onward Medical

Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with spinal cord injury (SCI) in the United States, Europe, and internationally. The company offers ARCEX System, an external stimulator that is intended to improve hand strength and sensation following SCI; ARCIM System, an implantable system currently used to explore potential indications in clinical feasibility studies; ARCBCI System, an implantable system currently being investigated to enable thought driven move...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2014
• Employees: 137
• Stock Exchange: OTCMKTS
• Ticker Symbol: ONWRF

Financial Performance

In 2025, Onward Medical's revenue was 5.41 million, an increase of 211.33% compared to the previous year's 1.74 million. Losses were -41.79 million, 17.0% more than in 2024.

Financial numbers in EUR